Distinguished Lecture Series: Michel Bouvier Ph.D.

Wed, 02/28/2018 - 11:30am to 12:30pm

The Ohio State University College of Pharmacy is pleased to present distinguished lecturer Michel Bouvier, PhD, professor of Biochemistry at the Institute for Research in Immunology and Cancer at the Université de Montréal and CEO of the Institute of Research in Immunology and Cancer for IRICoR, on February 28, 2018 at 11:30 a.m. in 103 Parks Hall.

Michel Bouvier holds a B.Sc. in biochemistry (1979) and a Ph.D in Neurological Sciences (1985) from the Université de Montréal and obtained post-doctoral training (1985-89) at Duke University under the supervision of Dr. R.J. Lefkowitz (Nobel prize Chemistry 2012). He is professor of Biochemistry and Molecular Medicine at the Faculty of Medicine of the Université de Montréal and principal investigator and at the Institute for Research in Immunology and Cancer. Dr. Bouvier is a world-renowned expert in the field of cell signalling and G protein-coupled receptors (GPCR) and made seminal contributions to our understanding of this major class of drug targets. His work on GPCR regulation led to paradigm shifts (inverse agonism, pharmacological chaperones, GPCR oligomerization, pluridimensionality of signalling), which coupled to his pioneering of bioluminescence resonance energy transfer (BRET) approaches, have direct impacts on drug discovery.

He is the author of over 260 scientific papers which received over 24,000 citations and delivered more than 400 invited conferences. He also holds 10 patents. His publications received more than 18,000 citations, leading to a Hirsh (h) index of 74 and his introduction on the 2014 Thomson Reuters’ list of the most cited scientists. His work was recognized by many awards, including his induction to the Academy of Sciences of the Royal Society of Canada in 2014. He trained 48 graduate students and 36 post-doctoral fellows, many of whom now hold professor and researcher positions around the world.

He currently holds the Canada research Chair in Signal Transduction and Molecular Pharmacology and is the general director of the Institute of Research in Immunology and Cancer.

103 Parks Hall
Category tag: 
Feb 28